Literature DB >> 31573544

Fabrication of poly(D, L-lactic acid) nanoparticles as delivery system for sustained release of L-theanine.

Chandrika Ravi1, Khan Zaved Ahmed2, Mandal Abul Kalam Azad3.   

Abstract

L-theanine is present in tea as a unique, free, non-protein amino acid. Due to various beneficial effects on brain activity, it is widely used as a nutraceutical. After consumption, it is rapidly absorbed and metabolised followed by excretion through urine. Therefore, the authors developed an L-theanine delivery system by encapsulating into polymeric nanoparticles to release it slowly and make it available for a longer period of time. Poly(D, L-lactic acid) nanoparticle (PLANP) was fabricated by the double emulsion method and L-theanine was encapsulated into it (PLANP-T). Spherical nanoparticles with a hydrodynamic diameter of 247 and 278 nm and surface charge of -14.5 and -25.7 mV for PLANP and PLANP-T, respectively, were fabricated. The Fourier transform infrared spectroscopic data indicated encapsulation of L-theanine into PLANP. The PLANP showed high L-theanine encapsulation capacity (71.65%) with a sustained release character. The maximum release (66.3%) of L-theanine was recorded in pH 7.3 at 48 h. The release kinetics followed the Higuchi model and the release mechanism was determined as super case-II transport (erosion). This slow release will make it available to the target tissue for a longer period of time (sustain release effect) and will also avoid immediate metabolism and clearance from the circulation.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31573544      PMCID: PMC8676538          DOI: 10.1049/iet-nbt.2018.5248

Source DB:  PubMed          Journal:  IET Nanobiotechnol        ISSN: 1751-8741            Impact factor:   1.847


  24 in total

1.  A 13-week dietary toxicity and toxicokinetic study with l-theanine in rats.

Authors:  J F Borzelleca; D Peters; W Hall
Journal:  Food Chem Toxicol       Date:  2006-04-26       Impact factor: 6.023

2.  Establishment of a knowledge base for identification of residual solvents in pharmaceuticals.

Authors:  Ying Liu; Chang-Qin Hu
Journal:  Anal Chim Acta       Date:  2006-06-06       Impact factor: 6.558

3.  Inhibiting effects of theanine on caffeine stimulation evaluated by EEG in the rat.

Authors:  T Kakuda; A Nozawa; T Unno; N Okamura; O Okai
Journal:  Biosci Biotechnol Biochem       Date:  2000-02       Impact factor: 2.043

4.  Metabolism of theanine, gamma-glutamylethylamide, in rats.

Authors:  T Unno; Y Suzuki; T Kakuda; T Hayakawa; H Tsuge
Journal:  J Agric Food Chem       Date:  1999-04       Impact factor: 5.279

5.  Transmural potential changes associated with the in vitro absorption of theanine in the guinea pig intestine.

Authors:  S Kitaoka; H Hayashi; H Yokogoshi; Y Suzuki
Journal:  Biosci Biotechnol Biochem       Date:  1996-11       Impact factor: 2.043

6.  Theanine, gamma-glutamylethylamide, is metabolized by renal phosphate-independent glutaminase.

Authors:  Haruhito Tsuge; Sachi Sano; Takashi Hayakawa; Takami Kakuda; Tomonori Unno
Journal:  Biochim Biophys Acta       Date:  2003-03-17

7.  Co-administration of l-cystine and l-theanine enhances efficacy of influenza vaccination in elderly persons: nutritional status-dependent immunogenicity.

Authors:  Koichi Miyagawa; Yoshimitsu Hayashi; Shigekazu Kurihara; Akiko Maeda
Journal:  Geriatr Gerontol Int       Date:  2008-12       Impact factor: 2.730

8.  Influence of experimental parameters on the characteristics of poly(lactic acid) nanoparticles prepared by a double emulsion method.

Authors:  M F Zambaux; F Bonneaux; R Gref; P Maincent; E Dellacherie; M J Alonso; P Labrude; C Vigneron
Journal:  J Control Release       Date:  1998-01-02       Impact factor: 9.776

9.  Involvement of GABA(A) receptors in the neuroprotective effect of theanine on focal cerebral ischemia in mice.

Authors:  Nobuaki Egashira; Kazuhide Hayakawa; Megumi Osajima; Kenichi Mishima; Katsunori Iwasaki; Ryozo Oishi; Michihiro Fujiwara
Journal:  J Pharmacol Sci       Date:  2007-10-06       Impact factor: 3.337

10.  The effects of L-theanine, caffeine and their combination on cognition and mood.

Authors:  Crystal F Haskell; David O Kennedy; Anthea L Milne; Keith A Wesnes; Andrew B Scholey
Journal:  Biol Psychol       Date:  2007-09-26       Impact factor: 3.251

View more
  1 in total

1.  Investigating preparation and characterisation of diphtheria toxoid-loaded on sodium alginate nanoparticles.

Authors:  Samira Aghamiri; Mojtaba Noofeli; Parvaneh Saffarian; Zahra Salehi Najafabadi; Hamid Reza Goudarzi
Journal:  IET Nanobiotechnol       Date:  2022-05-24       Impact factor: 2.050

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.